Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals, Inc.verified

ELDN

Price:

$4.83

Market Cap:

$288.54M

Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that is a molecule expressed on the surface of human immune system T cells, which is in Phase 2a clinical trials for the treatment of ALS, and Phase 2 clinical trials in islet cell transplantation for the treatment of type 1 diabetes. The company was formerly known as Novus Therapeutics, Inc. and changed its name to Eledon Pharmaceuticals, Inc. in January 2...[Read more]

Industry

Biotechnology

IPO Date

2014-09-17

Stock Exchange

NASDAQ

Ticker

ELDN

The Current Ratio as of December 2024 (TTM) for Eledon Pharmaceuticals, Inc. (ELDN) is 6.53

According to Eledon Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 6.53. This represents a change of -44.11% compared to the average of 11.68 of the last 4 quarters.

Eledon Pharmaceuticals, Inc. (ELDN) Historical Current Ratio (quarterly & annually)

How has ELDN Current Ratio performed in the past?

The mean historical Current Ratio of Eledon Pharmaceuticals, Inc. over the last ten years is 16.33. The current 6.53 Current Ratio has changed 3.90% with respect to the historical average. Over the past ten years (40 quarters), ELDN's Current Ratio was at its highest in in the December 2020 quarter at 46.57. The Current Ratio was at its lowest in in the March 2019 quarter at 3.18.

Quarterly (TTM)
Annual

Average

16.33

Median

12.05

Minimum

5.63

Maximum

46.57

Eledon Pharmaceuticals, Inc. (ELDN) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Eledon Pharmaceuticals, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 517.43%

Maximum Annual Current Ratio = 46.57

Minimum Annual Increase = -57.30%

Minimum Annual Current Ratio = 5.63

Quarterly (TTM)
Annual
YearCurrent RatioChange
202314.4156.77%
20229.19-54.21%
202120.07-56.89%
202046.57517.43%
20197.5433.88%
20185.63-57.30%
201713.1925.90%
201610.48-3.86%
201510.90-56.98%
201425.3473.95%

Eledon Pharmaceuticals, Inc. (ELDN) Average Current Ratio

How has ELDN Current Ratio performed in the past?

The current Current Ratio of Eledon Pharmaceuticals, Inc. (ELDN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

14.56

5-year avg

19.56

10-year avg

16.33

Eledon Pharmaceuticals, Inc. (ELDN) Current Ratio vs. Peers

How is ELDN’s Current Ratio compared to its peers?

Eledon Pharmaceuticals, Inc.’s Current Ratio is less than Inozyme Pharma, Inc. (7.68), less than Day One Biopharmaceuticals, Inc. (14.62), less than Terns Pharmaceuticals, Inc. (32.99), greater than HOOKIPA Pharma Inc. (3.26), greater than X4 Pharmaceuticals, Inc. (4.89), less than Acumen Pharmaceuticals, Inc. (10.43), greater than Amylyx Pharmaceuticals, Inc. (4.55), greater than Mereo BioPharma Group plc (6.10),

Build a custom stock screener for Eledon Pharmaceuticals, Inc. (ELDN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Eledon Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Eledon Pharmaceuticals, Inc. (ELDN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Eledon Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is Eledon Pharmaceuticals, Inc.'s Current Ratio?

How is the Current Ratio calculated for Eledon Pharmaceuticals, Inc. (ELDN)?

What is the highest Current Ratio for Eledon Pharmaceuticals, Inc. (ELDN)?

What is the 3-year average Current Ratio for Eledon Pharmaceuticals, Inc. (ELDN)?

What is the 5-year average Current Ratio for Eledon Pharmaceuticals, Inc. (ELDN)?

How does the current Current Ratio for Eledon Pharmaceuticals, Inc. (ELDN) compare to its historical average?